A deep dive discussion on Abivax with Truist Senior Biotech Analyst Gregory Renza
We discuss the upcoming maintenance data, commercial prospects, Crohn's, and buyout prospects.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.